3 hot insider trades: PNC chief picks up $1M in shares
PNC
+0.77%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
CMPX
-0.25%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
APLD
+21.67%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
By Davit Kirakosyan
Investing.com — Here are some of the biggest insider trades from the past week, as first reported on InvestingPro.
PNC Financial Services (NYSE:PNC) President/CEO, William Demchak, bought 6,550 shares, or over $1 million worth, at $153.38.
Shares rose more than 5% this week.
Applied Digital (NASDAQ:APLD) (formerly Applied Blockchain) CEO, Wes Cummins last week bought another 75,000 shares, or around $180,000 worth, at $2.33-$2.48. In the prior couple weeks, he had purchased 270,000 shares, or around $618,000 worth, at $2.17-$2.41.
Shares surged more than 33% this week.
Compass Therapeutics, Inc. (NASDAQ:CMPX) CEO, Thomas Schuetz, bought 20,000 shares, or $83,800 worth, at $4.19.
Among recent analyst actions at the company, Stifel initiated coverage on Compass with a Buy rating and a price target of $9.00. According to the firm, the recent presentation of updated results from the P2 trial of CTX-009 and paclitaxel combination in 2L BTC showed potential for a near $1 billion peak sales opportunity (worldwide) capable of providing >2x upside from current levels.
Shares closed the week with a 6% gain.
***
If you’re interested in upgrading your search for new investing ideas, check out InvestingPro.
